Periodic Reporting for period 1 - TREM2MEDS (Towards the clinical implementation of TREM2 Microglia Engineering for treating DementiaS)

TREM2MEDS emerges from the ERC PoC 2022 project TREM2μENGINES (Grant agreement ID: 101069395), which validated the efficacy of a novel treatment for Alzheimer’s Disease (AD) and Nasu-Hakola Disease (NHD) in murine models. A relevant proportion of AD cases and all forms of...